The Path to Clinical Relevance: Moving from Spatial Transcriptomics to Protein Profiling

Translational spatial biology enables you to progress from biomarker discovery to the development of clinically actionable panels that drive impactful patient outcomes. As discovery efforts using spatial transcriptomics generate an abundance of candidate biomarkers, translational researchers face the challenge of transforming these RNA insights into actionable protein panels.

Bridging the gap between transcriptomics and protein analysis is essential: while transcriptomics reveals a wealth of potential targets, only protein-level validation can confirm their biological and clinical significance. High-throughput, high-plex protein analysis is critical for efficiently evaluating these biomarkers across large studies – enabling robust microenvironment analysis and accelerating the path from discovery to clinical impact.

Want to learn how leading researchers are overcoming these challenges and advancing spatial biology from discovery to clinical applications?

Fill out the form to read the blog.